GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,074,000 | -29.9% | 25,051 | -50.0% | 0.12% | -40.9% |
| Q1 2020 | $4,387,000 | -16.3% | 50,101 | 0.0% | 0.20% | 0.0% |
| Q4 2019 | $5,239,000 | -29.4% | 50,101 | -22.3% | 0.20% | -38.9% |
| Q3 2019 | $7,419,000 | -33.3% | 64,499 | 0.0% | 0.32% | -28.6% |
| Q2 2019 | $11,119,000 | +89.0% | 64,499 | +84.9% | 0.45% | +90.0% |
| Q1 2019 | $5,882,000 | -4.7% | 34,891 | -44.9% | 0.24% | -9.5% |
| Q4 2018 | $6,169,000 | -18.1% | 63,345 | +45.3% | 0.26% | -3.3% |
| Q3 2018 | $7,531,000 | -24.5% | 43,598 | -39.0% | 0.27% | -28.0% |
| Q2 2018 | $9,977,000 | -20.1% | 71,497 | -35.5% | 0.38% | -21.9% |
| Q1 2018 | $12,482,000 | +278.2% | 110,784 | +343.1% | 0.48% | +281.9% |
| Q4 2017 | $3,300,000 | +58.4% | 25,000 | -16.7% | 0.13% | +67.1% |
| Q4 2015 | $2,083,000 | -83.2% | 30,000 | -77.8% | 0.08% | -82.9% |
| Q3 2015 | $12,372,000 | – | 135,400 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |